CHU de Poitiers Services Plateforme de recherche morphologique Publications
Pinel B, Duchesne M, Godet J, Milin S, Berger A, Wager M, Karayan-Tapon L. (2017). Mesenchymal subtype of glioblastomas with high DNA-PKcs expression is associated with better response to radiotherapy and temozolomide
Garcia M , Chomel JC , Mustapha P , Tran CT , Garnier M , Paris I , Quellard N , Godet J , Cremniter J , Bennaceur-Griscelli A , Lecron JC , Turhan AG , Burucoa C , Bodet C . (2016). In vitro culture and phenotypic and molecular characterization of gastric stem cells from human stomach Helicobacter. 2016 Sep 4. doi: 10.1111/hel.12351.Balbous A , Cortes U , Guilloteau K , Rivet P , Pinel B , Duchesne M , Godet J , Boissonnade O , Wager M , Bensadoun RJ , Chomel JC , Karayan-Tapon L . A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells .BMC Cancer. 2016 Aug 5;16:604.Pozdzik AA , Giordano L , Li G , Antoine MH , Quellard N , Godet J , De Prez E , Husson C , Declèves AE , Arlt VM , Goujon JM , Brochériou-Spelle I , Ledbetter SR , Caron N , Nortier JL . Blocking TGF-β Signaling Pathway Preserves Mitochondrial Proteostasis and Reduces Early Activation of PDGFRβ+ Pericytes in Aristolochic Acid Induced Acute Kidney Injury in Wistar Male Rats PLoS One. 2016 Jul 5;11(7):e0157288.Barbarin A, Séité P, Godet J, Bensalma S, Muller JM, Chadéneau (2014). Atypical nuclear localization of VIP receptors in glioma cell lines and patients .Biochem Biophys Res Commun. 2014 Nov 28;454(4):524-30.Debiais-Delpech C, Godet J, Pedretti N, Bernard FX, Irani J, Cathelineau X, Cussenot O, Fromont G. (2014). Expression patterns of candidate susceptibility genes HNF1 β and CtBP2 in prostate cancer: association with tumor progression.
Jardel P, Debiais C, Godet J, Irani J, Fromont G. Ductal carcinoma of the prostate shows a different immunophenotype from high grade acinar cancer.
Fromont G, Godet J, Peyret A, Irani J, Celhay O, Rozet F, Cathelineau X, Cussenot O. (2013). 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy.
Mathieu R, Evrard B, Fromont G, Rioux-Leclercq N, Godet J, Cathelineau X, Guillé F, Primig M, Chalmel F. (2013). Expression screening of cancer/testis genes in prostate cancer identifies NR6A1 as a novel marker of disease progression and aggressiveness. 73 , 1103-1114.
Fromont G , Godet J , Pires C , Yacoub M , Dore B , Irani J . (2012). Biological significance of perineural invasion (PNI) in prostate cancer .72 , 542-548.
